IN2012DN00534A - - Google Patents
Info
- Publication number
- IN2012DN00534A IN2012DN00534A IN534DEN2012A IN2012DN00534A IN 2012DN00534 A IN2012DN00534 A IN 2012DN00534A IN 534DEN2012 A IN534DEN2012 A IN 534DEN2012A IN 2012DN00534 A IN2012DN00534 A IN 2012DN00534A
- Authority
- IN
- India
- Prior art keywords
- ozone
- conditions
- dose
- disclosed
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Abstract
Methods of treating mammalian subjects suffering from or believed to be suffering from acute ischemic brain stroke cardiovascular disease inflammatory disease or any of the conditions or symptoms related to those diseases are disclosed in which a biological fluid withdrawn from the subject is processed through an ozone delivery system to deliver a measured amount of ozone to the biological fluid to produce a treated fluid that has a quantifiable absorbed-dose of ozone which upon re-introduction of the treated fluid containing the quantifiable absorbed-dose of ozone to the subject effectively treats any number of described disease conditions and symptoms. Methods for manufacturing medicaments for treatment of acute ischemic brain stroke cardiovascular disease inflammatory disease or any of the conditions or symptoms related to those diseases are also disclosed.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26909109P | 2009-06-19 | 2009-06-19 | |
US26909009P | 2009-06-19 | 2009-06-19 | |
US26908709P | 2009-06-19 | 2009-06-19 | |
US12/819,871 US20100318014A1 (en) | 2003-07-31 | 2010-06-21 | Treatment of acute ischemic brain stroke with ozone |
US12/819,886 US20100316727A1 (en) | 2003-07-31 | 2010-06-21 | Treatment of inflammatory disorders with ozone |
PCT/US2010/001785 WO2010147677A2 (en) | 2009-06-19 | 2010-06-21 | Treatment of inflammatory disorders, cardiovascular diseases and acute ischemic brain stroke with ozone |
US12/819,875 US20100316730A1 (en) | 2003-07-31 | 2010-06-21 | Treatment of cardiovascular diseases with ozone |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN00534A true IN2012DN00534A (en) | 2015-06-05 |
Family
ID=43356980
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN534DEN2012 IN2012DN00534A (en) | 2009-06-19 | 2010-06-21 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP2442819A4 (en) |
AU (1) | AU2010260467A1 (en) |
CA (1) | CA2765479A1 (en) |
IN (1) | IN2012DN00534A (en) |
WO (1) | WO2010147677A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018035504A1 (en) | 2016-08-19 | 2018-02-22 | Lane Ronald Howard | Gas treatment delivery systems and methods |
EP3500277A4 (en) * | 2016-08-19 | 2020-04-15 | Immunores-Therapeutics, LLC | Gas treatment delivery systems and methods |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2271190A1 (en) * | 1999-05-06 | 2000-11-06 | Vasogen Ireland Limited | Improved method for treating mammals with modified mammalian blood |
CA2296997A1 (en) * | 2000-01-18 | 2001-07-18 | Vasogen Ireland Limited | Treatment of congestive heart failure |
CA2308105A1 (en) * | 2000-05-11 | 2001-11-11 | Vasogen Ireland Limited | Treatment of il-10 deficiencies |
US7122208B2 (en) * | 2001-04-06 | 2006-10-17 | Vasogen Ireland Limited | Compositions containing apoptotic entities |
US7736494B2 (en) * | 2003-07-31 | 2010-06-15 | Acquisci, Inc. | Ozone delivery system including a variable pitch gas-fluid contact device |
TR200600945T1 (en) * | 2003-09-05 | 2006-10-26 | The Scripps Research Institute | Therapeutic methods. |
JP2005348774A (en) * | 2004-06-08 | 2005-12-22 | Masako Negishi | Treatment method for disease of animal and treatment apparatus for the same |
US20080138432A1 (en) * | 2004-07-20 | 2008-06-12 | Vasogen Ireland Limited | Acute Inflammatory Condition Treatment |
US20060210644A1 (en) * | 2004-12-16 | 2006-09-21 | Bruce Levin | Materials, methods, and devices for treatment of arthropathies and spondylopathies |
WO2007115398A1 (en) * | 2006-04-10 | 2007-10-18 | Vasogen Ireland Limited | Treatment of elevated c-reactive protein levels |
EP1932524A1 (en) * | 2006-12-13 | 2008-06-18 | Ludwig-Maximilians-Universität München | Pharmaceutical preparations for treating inflammatory diseases |
-
2010
- 2010-06-21 WO PCT/US2010/001785 patent/WO2010147677A2/en active Application Filing
- 2010-06-21 IN IN534DEN2012 patent/IN2012DN00534A/en unknown
- 2010-06-21 EP EP10789881A patent/EP2442819A4/en active Pending
- 2010-06-21 AU AU2010260467A patent/AU2010260467A1/en not_active Abandoned
- 2010-06-21 CA CA2765479A patent/CA2765479A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2442819A2 (en) | 2012-04-25 |
WO2010147677A2 (en) | 2010-12-23 |
EP2442819A4 (en) | 2013-01-02 |
WO2010147677A3 (en) | 2011-05-12 |
CA2765479A1 (en) | 2010-12-23 |
AU2010260467A1 (en) | 2012-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY188365A (en) | Diagnosis and treatments relating to th2 inhibition | |
PH12015500407B1 (en) | Methods of treating hypertriglyceridemia | |
MX2019002669A (en) | Methods of treating behavioral symptoms of neurological and mental disorders. | |
GB201016812D0 (en) | Method and apparatus for treating respiratory diesease | |
CR20110128A (en) | METHODS, SYSTEMS AND PRODUCTS TO PREACH THE RESPONSE OF TUMOR CELLS TO A THERAPEUTIC AGENT AND TREAT A PATIENT IN ACCORDANCE WITH THE PREDICTED RESPONSE | |
MX2019005130A (en) | Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin. | |
EA201101568A1 (en) | TREATMENT OF EX VIVO IMMUNOLOGICAL DISORDERS THROUGH PKC-TETA INHIBITORS | |
IL222251A0 (en) | Methods, system and apparatus for the detection, diagnosis and treatment of biological rhythm disorders | |
MX2013000674A (en) | Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy. | |
WO2015118537A3 (en) | Micro-rnas and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions | |
GB2477256A (en) | Medicament and method of diagnosis | |
EP4124346A3 (en) | Compositions and methods for treating diseases | |
FR2953395B1 (en) | ORTHOPEDIC SOLE COMPRISING CORRECTION MEANS FOR THE TREATMENT OF METATARSALGIA AND PLANT CUTANEOUS DISEASES | |
BR112012026224A2 (en) | methods for treating alzheimer's disease and for evaluating the effectiveness of a | |
HK1152649A1 (en) | Method for the identification of patients in need of therapy having minor cognitive disorders and the treatment of such patients | |
IN2012DN00534A (en) | ||
JP2014526564A5 (en) | ||
MX2022010890A (en) | Treatment and diagnosis of inflammatory disorders. | |
UA109359C2 (en) | TREATMENT OF SKIN DISEASES AND STATES | |
Khemthong et al. | Effect of musical training on reaction time: A randomized control trial in Thai elderly individuals. | |
FR2931075B1 (en) | FENUGREC EXTRACT FOR THE TREATMENT OF HUMAN AND ANIMAL DISEASES INVOLVING FLAGAL PARASITES | |
MX2014013380A (en) | Uses of cxcl17, a novel chemokine marker of human lung and gastrointestinal disease. | |
MX2011010920A (en) | Biomarker for monitoring patients. | |
MX2011010061A (en) | Biomarker for monitoring patients. | |
ATE498391T1 (en) | LIQUID COMPOSITION FOR THE TREATMENT AND/OR PREVENTION OF VARIOUS METABOLIC BONE DISEASES, USE THEREOF AND PREPARATION PROCESS. |